Triclosan: A critical review of the experimental data and development of margins of safety for consumer products
暂无分享,去创建一个
R. Maronpot | J. Swenberg | J. Borzelleca | J. Rodricks | A. Shipp | Joseph V� Rodricks | James A� Swenberg | Joseph F� Borzelleca | Robert R� Maronpot | Annette M� Shipp
[1] Y. J. Lin,et al. Triclosan: a safety profile. , 1989, American journal of dentistry.
[2] E. Somers. International Agency for Research on Cancer. , 1985, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[3] J. Toppari,et al. Expression of Peroxisome Proliferator-Activated Receptor α Messenger Ribonucleic Acid and Protein in Human and Rat Testis. , 1999, Endocrinology.
[4] S. Kersten,et al. Peroxisome proliferator-activated receptor α target genes , 2004, Cellular and Molecular Life Sciences CMLS.
[5] J. V. Vanden Heuvel,et al. Activation of mouse and human peroxisome proliferator-activated receptors (PPARs) by phthalate monoesters. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.
[6] M. Cunningham,et al. Differential activation of hepatic NF-kappaB in rats and hamsters by the peroxisome proliferators Wy-14,643, gemfibrozil, and dibutyl phthalate. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.
[7] J. Ashby,et al. Prediction of rodent nongenotoxic carcinogenesis: evaluation of biochemical and tissue changes in rodents following exposure to nine nongenotoxic NTP carcinogens. , 2002, Environmental health perspectives.
[8] H. K. Bojes,et al. Peroxisome proliferators activate Kupffer cells in vivo. , 1996, Cancer research.
[9] I. Rusyn,et al. Expression of base excision repair enzymes in rat and mouse liver is induced by peroxisome proliferators and is dependent upon carcinogenic potency. , 2000, Carcinogenesis.
[10] J. Auwerx,et al. Tissue Distribution and Quantification of the Expression of mRNAs of Peroxisome Proliferator–Activated Receptors and Liver X Receptor-α in Humans: No Alteration in Adipose Tissue of Obese and NIDDM Patients , 1997, Diabetes.
[11] R. Roberts,et al. The peroxisome proliferator (PP) response element upstream of the human acyl CoA oxidase gene is inactive among a sample human population: significance for species differences in response to PPs. , 1999, Carcinogenesis.
[12] C McNamara,et al. European consumer exposure to cosmetic products, a framework for conducting population exposure assessments. , 2007, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[13] U. Epa,et al. The Exposure Factors Handbook , 1995 .
[14] I. Rusyn,et al. Peroxisome proliferator-activated receptor alpha is restricted to hepatic parenchymal cells, not Kupffer cells: implications for the mechanism of action of peroxisome proliferators in hepatocarcinogenesis. , 2000, Carcinogenesis.
[15] V. Pirilä,et al. Allergy to ingredients of vehicles , 1976, Contact dermatitis.
[16] B C Allen,et al. Dose-response assessment for developmental toxicity. III. Statistical models. , 1994, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[17] Elaine M. Faustman,et al. Dose-response assessment for developmental toxicity , 1994 .
[18] I. Rusyn,et al. WY-14,643 induced cell proliferation and oxidative stress in mouse liver are independent of NADPH oxidase. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[19] C. Kimmel,et al. Dose-response assessment for developmental toxicity. II. Comparison of generic benchmark dose estimates with no observed adverse effect levels. , 1994, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[20] R. Remmel,et al. Concise review of the cytochrome P450s and their roles in toxicology. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.
[21] E. Larson,et al. Consumer antibacterial soaps: effective or just risky? , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[22] U. Epa. Guidelines for carcinogen risk assessment , 1986 .
[23] A. Dayan. Risk assessment of triclosan [Irgasan] in human breast milk. , 2007, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[24] M. Ishizuka,et al. PPARalpha-dependent modulation of hepatic CYP1A by clofibric acid in rats. , 2004, Archives of toxicology.
[25] Lin Yj,et al. Triclosan: a safety profile. , 1989, American journal of dentistry.
[26] Lin Yj,et al. Clinical evidence for the lack of triclosan accumulation from daily use in dentifrices. , 2000 .
[27] S. Veronesi,et al. Contact dermatitis to triclosan , 1986, Contact dermatitis.
[28] J. Hargreaves,et al. A gravimetric study of the ingestion of toothpaste by children. , 1972, Caries research.
[29] Alan R. Boobis,et al. IPCS Framework for Analyzing the Relevance of a Cancer Mode of Action for Humans , 2006 .
[30] Y. Ericsson,et al. Fluoride retained from mouthrinses and dentifrices in preschool children. , 1969, Caries research.
[31] Maria Pettersson,et al. Triclosan, a commonly used bactericide found in human milk and in the aquatic environment in Sweden. , 2002, Chemosphere.
[32] T. Maurer,et al. Predictive evaluation in animals of the contact allergenic potential of medically important substances , 1979, Contact dermatitis.
[33] H. Humphreys,et al. Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. , 2006, The Journal of hospital infection.
[34] A. Bircher,et al. Frequency of sensitization to 13 common preservatives in Switzerland * , 1994, Contact dermatitis.
[35] O. Mcbride,et al. cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor. , 1993, Biochemistry.
[36] S. E. Michaels,et al. Dentifrice Usage and Ingestion Among Four Age Groups , 1974, Journal of dental research.
[37] P. Thune,et al. The Scandinavian multicenter photopatch study , 1984, Contact dermatitis.
[38] J W Bridges,et al. Effects of phthalic acid esters on the liver and thyroid. , 1986, Environmental health perspectives.
[39] A. M. Api,et al. Exposure data for cosmetic products: lipstick, body lotion, and face cream. , 2005, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[40] P Grasso,et al. Hepatic peroxisome proliferation in rodents and its significance for humans. , 1993, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[41] B. Steinkjer,et al. Contact dermatitis from triclosan (Irgasan DP 300) , 1988, Contact dermatitis.
[42] H. Humphreys,et al. Erratum to “Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities [Journal of Hospital Infection 2006;63:S1–S44]” , 2006 .
[43] J. Gustafsson,et al. Structure of the mouse peroxisome proliferator activated receptor α gene , 1994 .
[44] H. Maibach,et al. A five-year study of cosmetic reactions. , 1985, Journal of the American Academy of Dermatology.
[45] P Fenner-Crisp,et al. Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans? , 1998, Regulatory toxicology and pharmacology : RTP.
[46] K. Woodcroft,et al. Xenobiotic-enhanced expression of cytochrome P450 2E1 and 2B1/2B2 in primary cultured rat hepatocytes. , 1995, Drug metabolism and disposition: the biological fate of chemicals.
[47] K. Woodcroft,et al. Differential effects of ciprofibrate on renal and hepatic cytochrome P450 2E1 expression. , 1996, Toxicology and applied pharmacology.
[48] E. Dooley. Household Products Database , 2003 .
[49] P. Carmichael,et al. Determination of genetic toxicity and potential carcinogenicity in vitro--challenges post the Seventh Amendment to the European Cosmetics Directive. , 2006, Mutagenesis.
[50] J. Bendig. Surgical hand disinfection: comparison of 4% chlorhexidine detergent solution and 2% triclosan detergent solution. , 1990, The Journal of hospital infection.
[51] B. Lake,et al. Comparative studies of the hepatic effects of di- and mono-n-octyl phthalates, di-(2-ethylhexyl) phthalate and clofibrate in the rat. , 2009, Acta pharmacologica et toxicologica.
[52] T. Langfitt. Hospital of the University of Pennsylvania. , 1992, Journal of neurosurgery.
[53] Emily K Gibson,et al. The effects of triclosan on puberty and thyroid hormones in male Wistar rats. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.
[54] Susan Budavari,et al. The Merck index : an encyclopedia of chemicals, drugs, and biologicals , 1983 .
[55] Anne Marie Api,et al. Exposure data for personal care products: hairspray, spray perfume, liquid foundation, shampoo, body wash, and solid antiperspirant. , 2006, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[56] Michael S McLachlan,et al. Triclosan in plasma and milk from Swedish nursing mothers and their exposure via personal care products. , 2006, The Science of the total environment.
[57] Carolyn Vickers,et al. IPCS framework for analysing the relevance of a cancer mode of action for humans , 2006 .
[58] Neal F Cariello,et al. Gene expression profiling of the PPAR-alpha agonist ciprofibrate in the cynomolgus monkey liver. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[59] W. Broeckx,et al. Cosmetic intolerance , 1987, Contact dermatitis.
[60] J. W. Weyland,et al. Contact allergy to preservatives (I) , 1986, Contact dermatitis.
[61] J. Griffith,et al. Expression of Base Excision DNA Repair Genes is a Sensitive Biomarker for In Vivo Detection of Chemical-Induced Chronic Oxidative Stress , 2004 .
[62] Stephen M Roberts,et al. Body Weight Distributions for Risk Assessment , 2007, Risk analysis : an official publication of the Society for Risk Analysis.
[63] J. Ward,et al. Differential susceptibility of mice humanized for peroxisome proliferator-activated receptor alpha to Wy-14,643-induced liver tumorigenesis. , 2006, Carcinogenesis.
[64] M. Ishizuka,et al. Down regulation of hepatic PPARα function by AhR ligand , 2004 .
[65] W. S. Snyder,et al. Report of the task group on reference man , 1979, Annals of the ICRP.
[66] J. Geier,et al. Patch testing with preservatives, antimicrobials and industrial biocides. Results from a multicentre study , 1998, The British journal of dermatology.
[67] J. W. Weyland,et al. Contact allergy to preservatives – II , 1986, Contact dermatitis.
[68] Samuel M Cohen,et al. Human carcinogenic risk evaluation: an alternative approach to the two-year rodent bioassay. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.
[69] R. Butler,et al. Use of 0.3% triclosan (Bacti-Stat) to eradicate an outbreak of methicillin-resistant Staphylococcus aureus in a neonatal nursery. , 1995, American journal of infection control.
[70] J. Konz,et al. Exposure factors handbook , 1989 .
[71] B. Lake. Peroxisome proliferation: current mechanisms relating to nongenotoxic carcinogenesis. , 1995, Toxicology letters.
[72] J. Baert,et al. The effect of sodium lauryl sulphate and triclosan on hamster cheek pouch mucosa , 1996, International journal of experimental pathology.
[73] T. Furia,et al. Toxicology of 2, 4, 4'-trichloro-2'-hydroxy-diphenyl ether. , 1969, IMS, Industrial medicine and surgery.
[74] Daniel R. Miller,et al. Final report , 2000 .
[75] K. Crofton,et al. Short-term in vivo exposure to the water contaminant triclosan: Evidence for disruption of thyroxine. , 2007, Environmental toxicology and pharmacology.
[76] James E Klaunig,et al. PPARalpha agonist-induced rodent tumors: modes of action and human relevance. , 2003, Critical reviews in toxicology.
[77] J. Lachapelle,et al. Low allergenicity of triclosan. Predictive testing in guinea pigs and in humans. , 1979, Dermatologica.
[78] J A Swenberg,et al. Kupffer cell oxidant production is central to the mechanism of peroxisome proliferators. , 1999, Carcinogenesis.
[79] A. Groot,et al. Patch tests with fragrance materials and preservatives , 1985, Contact dermatitis.
[80] R. Roberts,et al. Receptor-mediated hepatocarcinogenesis: role of hepatocyte proliferation and apoptosis. , 2002, Pharmacology & toxicology.
[81] Michael Müller,et al. Peroxisome Proliferator-Activated Receptor Alpha Target Genes , 2010, PPAR research.
[82] J. Toppari,et al. Expression of peroxisome proliferator-activated receptor alpha messenger ribonucleic acid and protein in human and rat testis. , 1999, Endocrinology.
[83] Ivan Rusyn,et al. Role of the Kupffer cell in mediating hepatic toxicity and carcinogenesis. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[84] D. Waxman,et al. Activation of PPARα and PPARγ by Environmental Phthalate Monoesters , 2003 .
[85] G. Rølla,et al. Triclosan protects the skin against dermatitis caused by sodium lauryl sulphate exposure. , 1994, Journal of clinical periodontology.
[86] P. Arni,et al. Intrasanguine host-mediated assay with Salmonella typhimurium. , 1977, Mutation research.
[87] Lyman Fl,et al. Toxicology of 2, 4, 4'-trichloro-2'-hydroxy-diphenyl ether. , 1968 .
[88] H. Maibach,et al. Antimicrobials: Experimental contact sensitization in man , 1973 .
[89] Y. J. Lin. Buccal absorption of triclosan following topical mouthrinse application. , 2000, American journal of dentistry.
[90] H. Maibach,et al. Results of standard patch tests with substances abandoned , 1982, Contact dermatitis.
[91] M. Ishizuka,et al. Down regulation of hepatic PPARalpha function by AhR ligand. , 2004, The Journal of veterinary medical science.
[92] M. Ishizuka,et al. AhR and PPARa: antagonistic effects on CYP2B and CYP3A, and additive inhibitory effects on CYP2C11 , 2005, Xenobiotica; the fate of foreign compounds in biological systems.
[93] D. Waxman,et al. Activation of PPARalpha and PPARgamma by environmental phthalate monoesters. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.
[94] Fung Kk,et al. Gingival absorption of triclosan following topical mouthrinse application. , 1994 .
[95] Vicki L Dellarco,et al. Mode of action in relevance of rodent liver tumors to human cancer risk. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[96] M. Ishizuka,et al. PPARα-dependent modulation of hepatic CYP1A by clofibric acid in rats , 2004, Archives of Toxicology.
[97] J. Gustafsson,et al. Structure of the mouse peroxisome proliferator activated receptor alpha gene. , 1994, Biochemical and biophysical research communications.
[98] D. Waxman,et al. Simultaneous, bidirectional inhibitory crosstalk between PPAR and STAT5b. , 2004, Toxicology and applied pharmacology.
[99] Y. J. Lin,et al. Clinical evidence for the lack of triclosan accumulation from daily use in dentifrices. , 2000, American journal of dentistry.
[100] Eckard Oberdisse,et al. Pharmakologie und Toxikologie: Arzneimittelwirkungen verstehen – Medikamente gezielt einsetzen , 2006 .
[101] C Kemmer,et al. Relationship between morphological changes and lipid-lowering action of p-chlorphenoxyisobutyric acid (CPIB) on hepatic mitochondria and peroxisomes in man. , 1983, Atherosclerosis.
[102] B. Lake,et al. A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines. , 1999, Regulatory toxicology and pharmacology : RTP.
[103] W. W. Nichols,et al. Growth regulation by peroxisome proliferators: opposing activities in early and late G1. , 1996, Cancer research.
[104] A. Calafat,et al. Pilot Study of Urinary Biomarkers of Phytoestrogens, Phthalates, and Phenols in Girls , 2006, Environmental health perspectives.
[105] Dana B Barr,et al. Estimating pesticide dose from urinary pesticide concentration data by creatinine correction in the Third National Health and Nutrition Examination Survey (NHANES-III) , 2004, Journal of Exposure Analysis and Environmental Epidemiology.
[106] Ivan Rusyn,et al. Modes of Action and Species-Specific Effects of Di-(2-ethylhexyl)Phthalate in the Liver , 2006, Critical reviews in toxicology.
[107] C. Anders,et al. Characterization of the hepatic responses to the short-term administration of ciprofibrate in several rat strain. Co-induction of microsomal cytochrome P-450 IVA1 and peroxisome proliferation. , 1990, Biochemical pharmacology.
[108] C McNamara,et al. Probabilistic modelling of European consumer exposure to cosmetic products. , 2007, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[109] D. Lai,et al. Rodent Carcinogenicity of Peroxisome Proliferators and Issues on Human Relevance , 2004, Journal of environmental science and health. Part C, Environmental carcinogenesis & ecotoxicology reviews.
[110] J. Harkness,et al. Successful control of endemic MRSA in a cardiothoracic surgical unit , 1990, The Medical journal of Australia.
[111] H. Glauert,et al. Expression of the hydrogen peroxide-generating enzyme fatty acyl CoA oxidase activates NF-kappaB. , 2000, DNA and cell biology.
[112] R. Cattley,et al. Peroxisome Proliferators and Receptor-Mediated Hepatic Carcinogenesis , 2004, Toxicologic pathology.
[113] K. Crofton,et al. Short-term exposure to triclosan decreases thyroxine in vivo via upregulation of hepatic catabolism in Young Long-Evans rats. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.
[114] H. Jinno,et al. Interaction of 2,4,4'-trichloro-2'-hydroxydiphenyl ether with microsomal cytochrome P450-dependent monooxygenases in rat liver. , 1996, Chemosphere.
[115] L. Mi,et al. The p53 status of Chinese hamster V79 cells frequently used for studies on DNA damage and DNA repair. , 1997, Nucleic acids research.
[116] S Kettle,et al. Mechanistically-based Human Hazard Assessment of Peroxisome Proliferator-induced Hepatocarcinogenesis , 1994, Human & experimental toxicology.
[117] I. Rusyn,et al. Novel role of oxidants in the molecular mechanism of action of peroxisome proliferators. , 2000, Antioxidants & redox signaling.
[118] D. Howes,et al. Percutaneous absorption and metabolism of Irgasan DP300. , 1975, Toxicology.
[119] L. B. Russell,et al. Use of the mouse spot test to investigate the mutagenic potential of triclosan (Irgasan DP300). , 1980, Mutation research.
[120] K. Griffin,et al. Peroxisome proliferator activated receptor-alpha expression in human liver. , 1998, Molecular pharmacology.
[121] G. Sandborgh-Englund,et al. Pharmacokinetics of Triclosan Following Oral Ingestion in Humans , 2006, Journal of toxicology and environmental health. Part A.
[122] A. Calafat,et al. Urinary Concentrations of Triclosan in the U.S. Population: 2003–2004 , 2007, Environmental health perspectives.
[123] R. Davies,et al. Fluoride ingestion from toothpaste by young children. , 1999, British dental journal.
[124] Jennifer Seed,et al. A Framework for Human Relevance Analysis of Information on Carcinogenic Modes of Action , 2003, Critical reviews in toxicology.
[125] J. Wahlberg. Routine patch testing with Irgasan DP 300® , 1976, Contact dermatitis.
[126] D. Howes,et al. Percutaneous absorption of Triclosan from toilet preparations , 1975 .
[127] R. Roberts,et al. Perturbation of rodent hepatocyte growth control by nongenotoxic hepatocarcinogens: mechanisms and lack of relevance for human health (review). , 1998, Oncology reports.
[128] T Sofuni,et al. A comparison of chromosome aberration induction by 25 compounds tested by two Chinese hamster cell (CHL and CHO) systems in culture. , 1990, Mutation research.
[129] D. Howes,et al. Percutaneous penetration and dermal metabolism of triclosan (2,4, 4'-trichloro-2'-hydroxydiphenyl ether). , 2000, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[130] David Y. Lai,et al. PPARα Agonist-Induced Rodent Tumors: Modes of Action and Human Relevance , 2003 .
[131] E. Guallar,et al. Serum Selenium Concentrations and Diabetes in U.S. Adults: National Health and Nutrition Examination Survey (NHANES) 2003–2004 , 2009, Environmental health perspectives.
[132] James E Klaunig,et al. The Human Relevance of Information on Carcinogenic Modes of Action: Overview , 2003, Critical reviews in toxicology.
[133] M. F. Weegels,et al. Variation of Consumer Contact with Household Products: A Preliminary Investigation , 2001, Risk analysis : an official publication of the Society for Risk Analysis.